Gross Profit Margin (Quarterly) Chart

View Gross Profit Margin (Quarterly) for HLBBF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Gross Profit Margin (Quarterly) Chart
Start Trial

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 1999. Start Trial.
Date Value
June 30, 2026 79.00%
March 31, 2026 80.03%
December 31, 2025 69.59%
September 30, 2025 85.53%
June 30, 2025 80.23%
March 31, 2025 81.37%
December 31, 2024 70.74%
September 30, 2024 80.09%
June 30, 2024 79.87%
March 31, 2024 80.06%
December 31, 2023 75.53%
September 30, 2023 76.88%
June 30, 2023 76.02%
March 31, 2023 78.43%
December 31, 2022 73.80%
September 30, 2022 78.51%
June 30, 2022 77.21%
March 31, 2022 79.60%
December 31, 2021 75.33%
September 30, 2021 77.32%
June 30, 2021 77.15%
March 31, 2021 76.64%
December 31, 2020 74.04%
September 30, 2020 70.38%
June 30, 2020 76.09%
Date Value
March 31, 2020 79.58%
December 31, 2019 74.71%
September 30, 2019 79.61%
June 30, 2019 79.77%
March 31, 2019 79.45%
December 31, 2018 78.93%
September 30, 2018 79.75%
June 30, 2018 79.67%
March 31, 2018 81.26%
December 31, 2017 76.91%
September 30, 2017 77.09%
June 30, 2017 75.86%
March 31, 2017 76.13%
December 31, 2016 73.54%
September 30, 2016 71.78%
June 30, 2016 71.63%
March 31, 2016 70.88%
December 31, 2015 64.26%
September 30, 2015 45.35%
June 30, 2015 63.82%
March 31, 2015 65.39%
December 31, 2014 61.87%
September 30, 2014 66.32%
June 30, 2014 69.46%
March 31, 2014 70.95%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
Novo Nordisk A/S 78.21%
ALK-Abello A/S 66.57%
AstraZeneca PLC 76.09%
ANI Pharmaceuticals, Inc. 54.97%
Corcept Therapeutics, Inc. 98.41%

Gross Profit Margin (Quarterly) Related Metrics